-
Reactive Oxygen Species Assay Kit: DHE in Macrophages
2026-09-09
Explore how the Reactive Oxygen Species Assay Kit (DHE) can connect intracellular superoxide measurement with DON-induced macrophage immunotoxicity. This evidence-led guide explains assay chemistry, controls, interpretation limits, and orthogonal validation strategies.
-
Hexose Diphosphate: From Flux to Inflammation
2026-09-09
Explore how hexose diphosphate connects glycolytic flux, energy homeostasis research, ischemia biology, and inflammation-focused assay design. This guide distinguishes its metabolic role from phosphoenolpyruvate and translates recent cGAS–STING findings into practical experimental decisions.
-
Sodium Nitroprusside for Reliable Cell Assays
2026-09-08
This scenario-based guide explains how Sodium Nitroprusside, SKU B2026, can be incorporated into cell viability, proliferation, cytotoxicity, vascular, and platelet workflows without confusing nitric oxide biology with assay artifacts. It connects practical formulation choices with published sex-dependent hypertension data and provides protocol and vendor-selection guidance.
-
From LACTB Biology to Smarter Apoptosis Studies
2026-09-08
LACTB provides a mechanistic entry point into mitochondrial apoptosis by remodeling the inner mitochondrial membrane and promoting cytochrome c release. This article explains how Q-VD-OPh can help translational researchers separate upstream mitochondrial events from downstream caspase execution while improving experimental control across apoptosis, neurodegeneration, and cell-recovery workflows.
-
Bile Acid Retention and Immune Escape in MASH-HCC
2026-09-07
A 2026 Cancer Letters study identifies a GPR120–FXR/ABCB11–bile acid–NLRC5 pathway that links lipid-associated metabolic dysfunction to defective MHC-I antigen presentation in MASH-HCC. The findings suggest that reducing intracellular bile acid retention can restore tumor antigenicity and improve anti-PD-1 responses, while also providing a framework for mechanistic antigen-presentation assays.
-
Metal-Ion-Chelating l-Phe Nanostructures Enhance ICB
2026-09-07
This Nature Nanotechnology study shows that metal-ion-chelating l-phenylalanine nanostructures can remodel immunosuppressive breast and colorectal tumour microenvironments and improve immune checkpoint blockade responses. Its central innovation is the use of electrophysiological modulation, inflammasome signaling, and short-term starvation to activate dendritic cells and strengthen tumour-specific cytotoxic T-cell immunity.
-
7-dehydro Cholesterol: Workflow & Applications
2026-09-05
Use 7-dehydro Cholesterol to connect DHCR7 activity with sterol flux, UVB-driven vitamin D3 formation, oxidation, and immune phenotypes. This practical guide translates a 2026 dhcr7 knockout grass carp study into assay design, controls, optimization steps, and troubleshooting decisions.
-
LSKL Reduces Oxidative Stress in a PCOS Model
2026-09-04
The reference study identifies THBS1 inhibition by LSKL as a potential mechanism for reducing DHEA-induced oxidative stress and apoptosis in rat granulosa cells. By combining molecular docking, cellular assays, and a rat model, it links ovarian protection with restoration of PI3K/AKT signaling, improved hormone balance, and recovery of ovarian morphology.
-
Risedronate Sodium: FPP Synthase Inhibitor Workflows
2026-09-04
Risedronate Sodium enables mechanism-led studies of osteoclast activity, bone remodeling, delivery systems, and exploratory tumor-cell phenotypes. This workflow-focused guide connects FPPS inhibition with practical dosing, assay design, formulation handling, and troubleshooting across bone and lung research.
-
Parathyroid hormone (1-34) (human): Mechanism
2026-09-03
Parathyroid hormone (1-34) (human) is a defined PTH (1-34) peptide fragment that activates calcium-regulatory signaling and supports bone metabolism research. Its receptor-binding, cAMP, solubility, storage, and in vivo bone-mass benchmarks are product-specific measurements and should not be interpreted as clinical dosing guidance.
-
FGFR–TGFβ–PI3K/AKT Control of Periostin
2026-09-03
Labrèche et al. identified a pathway cross talk that controls periostin expression in Neu-positive breast cancer cells, linking FGF/FGFR, TGFβ, PKC, and PI3K/AKT signaling. The study helps explain how epithelial tumor cells acquire periostin expression and provides a framework for interpreting tumor-cell and stromal contributions to the breast cancer microenvironment.
-
Vitamin C in Senescence and Cancer Workflows
2026-09-02
Discover how Vitamin C and ascorbic acid can be deployed in oxidative-stress, cellular-senescence, and cancer research workflows. This guide connects a D-galactose-induced HEI-OC1 model with practical assay design, dose selection, controls, and troubleshooting for reproducible results.
-
Dynasore: Practical Workflow for Endocytosis Studies
2026-09-02
Dynasore is a cell-permeable dynamin GTPase inhibitor for reversible, dose-dependent perturbation of dynamin-dependent endocytosis and vesicle trafficking. It is useful for controlled cellular pathway studies, but should not be treated as a dynamin1, dynamin2, or Drp1-specific probe or as evidence of therapeutic activity.
-
Humanized Mice Improve CES Prodrug PK Prediction
2026-09-01
This 2025 study shows that humanized-liver mice can reduce species-related uncertainty when evaluating the carboxylate ester prodrug HD56 and its active metabolite HD561. By integrating transporter, enzyme, microsomal, plasma, and pharmacokinetic experiments, the authors establish a strong in vivo–in vitro correlation that supports more human-relevant prodrug development.
-
MK-571: From Airway Signaling to Translational Insight
2026-09-01
MK-571 (L-660,711) is best understood as a mechanistic bridge between cysteinyl leukotriene receptor biology and MRP1/ABCC1-mediated transport. This thought-leadership guide shows translational researchers how to use the compound in airway, macrophage, and cytotoxicity assays while avoiding pathway misattribution.